Erschienen in:
01.06.2014 | Original Article
Depressive Symptom Trajectories During and After Adjuvant Treatment for Breast Cancer
verfasst von:
Kristine A. Donovan, Ph.D., Brian D. Gonzalez, Ph.D., Brent J. Small, Ph.D., Michael A. Andrykowski, Ph.D., Paul B. Jacobsen, Ph.D.
Erschienen in:
Annals of Behavioral Medicine
|
Ausgabe 3/2014
Einloggen, um Zugang zu erhalten
Abstract
Background
The course of depressive symptoms during and after breast cancer treatment is not well understood.
Purpose
We identified patient subgroups based on distinct trajectories of depressive symptoms and determined whether subgroups could be distinguished by personal characteristics and coping strategies.
Methods
Breast cancer patients completed the Center for Epidemiologic Studies–Depression Scale on clinically meaningful occasions and during the posttreatment period. The Illness Management Questionnaire was completed prior to treatment.
Results
A three-class mixture model provided the best fit to the data. Subgroup membership was significantly (p < .05) associated with marital status, history of depression, and focusing on symptoms. In multivariate analysis, marital status and focusing on symptoms remained significant (p < .05) predictors of subgroup membership.
Conclusions
Distinct trajectories can be identified during and after adjuvant breast cancer therapy. Predictors of these trajectories have implications for addressing depressive symptoms in this clinical population and for future research.